Quantum-Si to Present Research and Development Updates at the VIB Next-Generation Protein Analysis and Detection Conference

GUILFORD, Conn.–(BUSINESS WIRE)– May 17, 2022–Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing single molecule protein sequencing, today announced that it will be participating in the Next-Generation Protein Analysis and Detection Conference, a VIB Tools & Technologies conference, taking place in Ghent, Belgium on May 30-31, 2022.

Brian Reed, Ph.D., Head of Research, will provide an update on the Company’s research and development progress in an oral presentation titled, “Real-time dynamic single-molecule protein sequencing on the Quantum-Si platform,” on Tuesday, May 31, 2022 at 2:40 – 3:05 PM CEST. The presentation abstract is available until August 30, 2022 for registered attendees of the event.

About Quantum-Si Incorporated

Quantum-Si is focused on revolutionizing the growing field of proteomics. The Company’s suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single molecule next-generation protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at quantumsi.supremeclients.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220516006027/en/

Investor
Juan Avendano
Mike Cavanaugh
[email protected]

Media
Karen Chase
[email protected]

Source: Quantum-Si Incorporated